亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Anti-Microbial Contact Lens With Ocular Drug Delivery

技术优势
Controlled and effective ocular therapeutic drug release profiles Anti-microbial surface aiding in prolonged device use without acquiring an infection Affordable therapeutic
技术应用
-Slow continuous ocular therapeutic delivery to treat bacterial infections. -Eye post-operative medication administration -Preventing microbial infections in the eye
详细技术说明
Contacts lenses are ubiquitous medical devices with more than 30 million contact lens users in the U.S. Shockingly, one million users every year contract an infection from either bacteria or fungi infections that originates on the surfaces of contact lenses. The current standard of care to treat infections are antibiotic eye drop solution; however, such treatments are limited in effectiveness as eye drops are quickly washed away by natural tears before they can take full therapeutic effect. There is a clinical unmet need for a robust and controllable method to deliver antibiotic ocular therapeutics. Researchers at the University of California, Irvine, have invented a transparent, anti-microbial, anti-fungal, drug eluting ocular device/contact lens to precisely deliver ocular therapeutics to treat and prevent infection. Also, the surfaces of the contact lens itself prevents bacterial growth. Such contact lenses can be used towards the prevention of ocular infection and as a post-operative pain and infection management medical device.
*Abstract

Anti-microbial, anti-fungal drug eluting contact lens for the controlled release of ophthalmic therapeutics.

*Principal Investigation

Name: Mary Dickson

Department:


Name: Elena Liang

Department:


Name: Rachel Rosenzweig

Department:


Name: Szu-Wen Wang

Department:


Name: Albert Fan Yee

Department:

其他

State Of Development

The inventor has completed the concept phase of the invention and is now experimenting with the anti-bacterial, anti-fungal, and ocular drug delivery properties.


Tech ID/UC Case

28678/2017-421-0


Related Cases

2017-421-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备